I am a
Home I AM A Search Login

Papers of the Week

2022 Mar 03

Acta Neurol Scand

Treatment satisfaction with calcitonin gene-related peptide monoclonal antibodies as a new patient-reported outcome measure: A real-life experience in migraine.


To evaluate treatment satisfaction with galcanezumab as a patient-reported outcome measure (PROM) in migraine.